cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25582/data.2023-03.2764892/2322033
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765942/2322034
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766789/2322035
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766900/2322036
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766061/2322037
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766098/2322038
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765792/2322039
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2763769/2322040
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765722/2322041
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764044/2322042
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764968/2322043
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765882/2322044
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764820/2322045
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765521/2322046
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765533/2322047
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2763962/2322048
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764793/2322049
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765400/2322050
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765758/2322051
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764871/2322052
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765471/2322053
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765766/2322054
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765372/2322055
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765494/2322056
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765028/2322057
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765829/2322058
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765118/2322059
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2763993/2322060
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2763892/2322061
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764521/2322062
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765784/2322063
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765046/2322064
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766937/2322065
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765063/2322066
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765652/2322067
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2763914/2322068
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764853/2322069
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765179/2322070
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765951/2322071
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766781/2322072
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2763870/2322073
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765321/2322074
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765595/2322075
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764065/2322076
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766923/2322077
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765863/2322078
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765267/2322079
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765500/2322080
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765044/2322081
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2763923/2322082
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766036/2322083
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765142/2322084
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765805/2322085
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766922/2322086
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765848/2322087
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765952/2322088
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765129/2322089
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765743/2322090
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766624/2322091
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765499/2322092
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764389/2322093
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764099/2322094
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766305/2322095
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765027/2322096
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764916/2322097
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2763858/2322098
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2763985/2322099
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765855/2322100
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765762/2322101
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765800/2322102
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766791/2322103
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765646/2322104
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764989/2322105
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765968/2322106
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2763912/2322107
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764570/2322108
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765584/2322109
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764551/2322110
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764868/2322111
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765186/2322112
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764935/2322113
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765793/2322114
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764995/2322115
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764834/2322116
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765577/2322117
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765524/2322118
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765716/2322119
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765096/2322120
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765483/2322121
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2763955/2322122
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765225/2322123
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765587/2322124
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766021/2322125
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766897/2322126
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2763795/2322127
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765176/2322128
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765552/2322129
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766233/2322130
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2764014/2322131
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2766524/2322132
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765206/2322133
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765303/2322134
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765574/2322135
title: Data for EMSL Project 51287 from March 2023
DOI: 10.25582/data.2023-03.2765616/2322136
title: Data for EMSL Project 51287 from March 2023
DOI: 10.6084/m9.figshare.25377754
title: 多粘菌Paenibacillus polymyxa KBMA4-1通过改善仔猪肠道菌群和代谢产物，改善仔猪的生长性能和碳水化合物代谢。

description: 本研究旨在探讨产生淀粉酶的多粘杆菌菌株对断奶仔猪生长性能、能量代谢和肠道菌群的影响。我们筛选了一种从成年猪空肠分泌淀粉酶的多粘假单胞菌菌株。然后是38头杂交仔猪（约克郡×长白;28日龄），随机分为两组。对照组 （Con） 饲喂基本饮食，而多粘疟原虫 KBMA4-1 （Pol） 组饲喂基本饮食 + 多粘疟原虫 KBMA4-1 （1× 109 CFU/mL;10毫升）。结果表明，多粘假单胞菌KBMA4-1显著改善断奶仔猪的生长和能量代谢（P &lt; 0.05）。多粘疟原虫 KMBA-1 可能通过增加肠道中乳酸脱氢酶的相对表达来促进 L-乳酸的产生。L-乳酸增加断奶仔猪的糖异生，从而改善仔猪的碳水化合物代谢。
DOI: 10.6084/m9.figshare.25377754.v1
title: 多粘菌Paenibacillus polymyxa KBMA4-1通过改善仔猪肠道菌群和代谢产物，改善仔猪的生长性能和碳水化合物代谢。

description: 本研究旨在探讨产生淀粉酶的多粘杆菌菌株对断奶仔猪生长性能、能量代谢和肠道菌群的影响。我们筛选了一种从成年猪空肠分泌淀粉酶的多粘假单胞菌菌株。然后是38头杂交仔猪（约克郡×长白;28日龄），随机分为两组。对照组 （Con） 饲喂基本饮食，而多粘疟原虫 KBMA4-1 （Pol） 组饲喂基本饮食 + 多粘疟原虫 KBMA4-1 （1× 109 CFU/mL;10毫升）。结果表明，多粘假单胞菌KBMA4-1显著改善断奶仔猪的生长和能量代谢（P &lt; 0.05）。多粘疟原虫 KMBA-1 可能通过增加肠道中乳酸脱氢酶的相对表达来促进 L-乳酸的产生。L-乳酸增加断奶仔猪的糖异生，从而改善仔猪的碳水化合物代谢。
DOI: 10.18112/openneuro.ds005021.v1.2.0
title: Tilt Illusion by Phase
DOI: 10.5517/ccdc.csd.cc2fgln5
title: CCDC 2248357: Experimental Crystal Structure Determination

description: Related Article: William E. Meador, Timothy A. Lewis, Abdul K. Shaik, Kalpani Hirunika Wijesinghe, Boqian Yang, Amala Dass, Nathan I. Hammer, Jared H. Delcamp|2024|J.Org.Chem.|89|2825|doi:10.1021/acs.joc.3c01917
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2h6gjq
title: CCDC 2300123: Experimental Crystal Structure Determination

description: Related Article: Kaifa Zhang, Changhong Liu, Dilshat Abdukerem, Zechuan Mao, Wenli Zhu, Kun Xia, Ablimit Abdukader|2024|J.Org.Chem.|89|3049|doi:10.1021/acs.joc.3c02518
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.25946/25265305
title: Bioactive compounds and fatty acids in Sesame cake

description: Black sesame has a high-value cash crop, multiple applications in terms of health-benefitting compounds in the seed, oil, and pressed seedcake. Previous research efforts and including the warmest season sesame harvesting, opened an opportunity for the CQUniversity in collaboration with the CRC for Northern Australia and Agriventis Technologies Ltd Pty, for further investigation and potential use in future breeding programs. Although, only 525 hectares of land are annually sown in Australia, hence, there is a golden window for Australia to become a leading trader of this product, due to the lack of research in the nutritional compounds of the black sesame seed, oil and pressed seedcake, as well as contributing valuable information allowing farmers to capitalise on this international market. The contribution of this study, particularly in the sesame derivatives, may lead to the recommend guideline for the selection of ideal black sesame seed lines best suited for its expansion in the northern Australia cropping industry, by using material from earlier conducted growing trials
DOI: 10.25946/25265305.v1
title: Bioactive compounds and fatty acids in Sesame cake

description: Black sesame has a high-value cash crop, multiple applications in terms of health-benefitting compounds in the seed, oil, and pressed seedcake. Previous research efforts and including the warmest season sesame harvesting, opened an opportunity for the CQUniversity in collaboration with the CRC for Northern Australia and Agriventis Technologies Ltd Pty, for further investigation and potential use in future breeding programs. Although, only 525 hectares of land are annually sown in Australia, hence, there is a golden window for Australia to become a leading trader of this product, due to the lack of research in the nutritional compounds of the black sesame seed, oil and pressed seedcake, as well as contributing valuable information allowing farmers to capitalise on this international market. The contribution of this study, particularly in the sesame derivatives, may lead to the recommend guideline for the selection of ideal black sesame seed lines best suited for its expansion in the northern Australia cropping industry, by using material from earlier conducted growing trials
DOI: 10.18112/openneuro.ds005021.v1.2.1
title: Tilt Illusion by Phase
DOI: 10.6084/m9.figshare.25377775.v1
title: Supplementary Material for: Long-term efficacy and safety of enzalutamide monotherapy in elderly patients with metastatic castration-resistant prostate cancer - case report

description: Prostate cancer is one of the most common cancers in men. Despite the sharp rise in incidence, mortality is decreasing. ARTA preparations are preferred options for asymptomatic or mildly symptomatic patients with mCRPC. The use of enzalutamide in elderly patients with mCRPC is risky and depends on a number of factors. An increased risk of falls and fractures has been shown. We present a case report of an elderly patient with mCRPC treated with enzalutamide with very good long-term tolerance and efficacy. Despite the older age, no reduction of therapy was necessary in the patient due to good tolerance. Administration of enzalutamide in full doses resulted in a very good effect of therapy.
DOI: 10.6084/m9.figshare.25377775
title: Supplementary Material for: Long-term efficacy and safety of enzalutamide monotherapy in elderly patients with metastatic castration-resistant prostate cancer - case report

description: Prostate cancer is one of the most common cancers in men. Despite the sharp rise in incidence, mortality is decreasing. ARTA preparations are preferred options for asymptomatic or mildly symptomatic patients with mCRPC. The use of enzalutamide in elderly patients with mCRPC is risky and depends on a number of factors. An increased risk of falls and fractures has been shown. We present a case report of an elderly patient with mCRPC treated with enzalutamide with very good long-term tolerance and efficacy. Despite the older age, no reduction of therapy was necessary in the patient due to good tolerance. Administration of enzalutamide in full doses resulted in a very good effect of therapy.
DOI: 10.6084/m9.figshare.25377934
title: Supplementary Material for: Capecitabine-related fourth nerve palsy: a case report

description: Introduction: Capecitabine has rarely been associated with neurotoxicity. Cerebellar ataxia, multifocal leukoencephalopathy, and sensorimotor peripheral neuropathy have been reported in the literature. A case of 6th nerve palsy associated with capecitabine has also been described. This article reports the first case of capecitabine-related 4th nerve palsy. 
Case presentation: A 72-year-old Caucasian woman was referred by the Oncology Department because she had been complaining of binocular diplopia for six months. The symptoms started one month after the introduction of capecitabine. A diagnosis of right 4th nerve palsy was made using the Parks three-step test and the Hess test. Neuroimaging analysis was negative. A slow but progressive deterioration of function was confirmed during a year of follow-up. On suspicion of a chemotherapy-related palsy, capecitabine was discontinued and switched to vinorelbine. Subsequent improvement of the clinical picture was confirmed within 2 months. 
Conclusion: The recognition of chemotherapy-related neurotoxicity is of paramount importance in the management of oncology patients. Once secondary invasion of the brain or the orbit by the tumor itself is ruled out, it must be suspected to prevent further deterioration.
DOI: 10.6084/m9.figshare.25377934.v1
title: Supplementary Material for: Capecitabine-related fourth nerve palsy: a case report

description: Introduction: Capecitabine has rarely been associated with neurotoxicity. Cerebellar ataxia, multifocal leukoencephalopathy, and sensorimotor peripheral neuropathy have been reported in the literature. A case of 6th nerve palsy associated with capecitabine has also been described. This article reports the first case of capecitabine-related 4th nerve palsy. 
Case presentation: A 72-year-old Caucasian woman was referred by the Oncology Department because she had been complaining of binocular diplopia for six months. The symptoms started one month after the introduction of capecitabine. A diagnosis of right 4th nerve palsy was made using the Parks three-step test and the Hess test. Neuroimaging analysis was negative. A slow but progressive deterioration of function was confirmed during a year of follow-up. On suspicion of a chemotherapy-related palsy, capecitabine was discontinued and switched to vinorelbine. Subsequent improvement of the clinical picture was confirmed within 2 months. 
Conclusion: The recognition of chemotherapy-related neurotoxicity is of paramount importance in the management of oncology patients. Once secondary invasion of the brain or the orbit by the tumor itself is ruled out, it must be suspected to prevent further deterioration.
DOI: 10.6084/m9.figshare.25378186.v1
title: Supplementary Material for: INCIDENCE OF MULTIPLE SCLEROSIS IN URUGUAY. A PROSPECTIVE POPULATION-BASED STUDY

description: Background
The worldwide incidence of multiple sclerosis (MS) is estimated at 0.5-10 cases per 100,000 person-years and is probably increasing. In 2014, a previous study estimated the incidence of multiple sclerosis in Uruguay at 1.2 cases per 100.000 person-years.

Objectives
We conducted an observational, prospective, population-based study to determine MS incidence from diagnosis in Uruguay. 

Methods
The population studied included people older than 18 years of age, who were living in Uruguay between July 1, 2019, and June 30, 2021. The diagnosis was based on 2017 McDonald criteria. Multiple data sources were employed including neurologists, magnetic resonance imaging centers, laboratories performing oligoclonal band testing, neurophysiology laboratories, neurorehabilitation centers, the institution Fondo Nacional de Recursos, and the MS Patients’ Association of Uruguay (EMUR). The capture-recapture method was used to estimate incidence.

Results
155 new MS cases were confirmed after review. The median age was 35 (range 18-62). Thirteen patients (8.38%) were diagnosed with late onset MS.
The crude incidence rate was 2.89 cases per 100,000 person-years, 3.95 among female and 1.72 among male patients. The incidence rate estimated using the capture-recapture method was 3.18 (95% CI 3.02-3.34). 

Conclusions 
According to the Atlas of MS, Uruguay has a low incidence rate (2.0-3.99), even though it is one of the highest in Latin America. Our country aligns with the global trend of increasing incidence. Age and sex distribution were similar to other studies, with a high incidence of patients with late onset multiple sclerosis. The capture-recapture method confirms the exhaustivity of our investigation.
DOI: 10.5281/zenodo.10278759
title: Temperature, pressure, permebility datasets of a 2D hydrothermal model

description: The numerical datasets are temperatures, pressures, permeabilities of a 2D natural-state hydrothermal system simulated using TOUGH2.

The numerical datasets were used to evaluate a neural network proposed in the following article:

Ishitsuka et al. Modeling unobserved geothermal structures using a physics-informed deep neural network with transfer learning of prior knowledge, under review.

#----------------------------------------------------------------------------------------------

(Dataset 1: Dataset_Reference.csv, Pretrain_Datasets.zip)

The hydrothermal system had a 2D space with a horizontal width of 2 km and a depth of 1.6 km. The system consists of five geological units with different permeability, and had a fault-controlled permeable region extending vertically. The hydrothermal fluid flowed though the vertical permeable zone.

(Dataset2: Dataset_Reference_Ungaran-Base.csv, Pretrain_Datasets_Ungaran-Base.zip)

The permeability structure of the numerical model is constructed based on the hydrothermal model in Jatmiko et al. (2022). A 10 km long and 5 km deep region of the numerical model is divided into 5,000 elements at 100 m intervals. In the hydrothermal model, the hydrothermal upflow zone is around the summit of the mountain.

Jatmiko BW et al. Resource assessment of Ungaran geothermal field using numerical model and monte carlo simulation. IOP Conference Series: Earth and Environmental Science 2022;1031:2021.

#----------------------------------------------------------------------------------------------
DOI: 10.5281/zenodo.10278760
title: Temperature, pressure, permebility datasets of a 2D hydrothermal model

description: The numerical datasets are temperatures, pressures, permeabilities of a 2D natural-state hydrothermal system simulated using TOUGH2. The hydrothermal system had a 2D space with a horizontal width of 2 km and a depth of 1.6 km. The system consists of five geological units with different permeability, and had a fault-controlled permeable region extending vertically. The hydrothermal fluid flowed though the vertical permeable zone.
The numerical datasets were used to evaluate a neural network proposed in the following article:
Ishitsuka et al. Modeling natural-state geothermal systems using a physics-informed neural network with transfer learning of expert knowledge, under review.